We are live on ! Find out more
CPHI icon

China Pharma Holdings
CPHI

7 hedge funds and large institutions have $650K invested in China Pharma Holdings in 2016 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

22% more capital invested

Capital invested by funds: $533K → $650K (+$117K)

0% more funds holding

Funds holding: 7 → 7 (0)

0% more ownership

Funds ownership: 0.01% → 0.01% (+0%)

0% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 2

Holders
7
Holders Change
–
Holders Change %
0%
% of All Funds
0.17%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
1
Reduced
–
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
VKH
Virtu KCG Holdings
New York
+$5.85K
2
Citadel Advisors
Citadel Advisors
Florida
+$3.4K
3
Renaissance Technologies
Renaissance Technologies
New York
+$2.87K

Top Sellers

1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$7K
2
UBS Group
UBS Group
Switzerland
-$1.7K
Name Holding Trade Value Shares
Change 		Change in
Stake
PAM
1
Pope Asset Management
Tennessee
$546K – – –
GA
2
Glenhill Advisors
New York
$52K – – –
Renaissance Technologies
3
Renaissance Technologies
New York
$35K +$2.87K +27 +11%
VKH
4
Virtu KCG Holdings
New York
$7K +$5.85K +55 New
Citadel Advisors
5
Citadel Advisors
Florida
$4K +$3.4K +32 New
Goldman Sachs
6
Goldman Sachs
New York
$3K – – –
PCM
7
Parsons Capital Management
Rhode Island
$3K – – –
Susquehanna International Group
8
Susquehanna International Group
Pennsylvania
– -$7K -66 Closed
UBS Group
9
UBS Group
Switzerland
– -$1.7K -16 Closed

CPHI Hedge Fund Activity: Q4 2016 in Review

7 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in China Pharma Holdings (CPHI) for Q4 2016, worth a combined $650K — up 22% from $533K a quarter earlier.

Fund positioning in CPHI was balanced in Q4 2016: 2 funds opened new positions, 2 closed out, 1 added to existing stakes and 0 trimmed.

The largest buyer was Virtu KCG Holdings, opening a new position worth an estimated $5.85K. The largest seller was Susquehanna International Group, exiting entirely with an estimated $7K sold.

  • 7 institutional investors held China Pharma Holdings (CPHI) as of Q4 2016, unchanged from Q3 2016.
  • Funds reported $650K of China Pharma Holdings stock for Q4 2016, up 22% quarter-over-quarter.
  • 2 funds opened new China Pharma Holdings positions in Q4 2016 and 2 closed out, a net change of 0 holders.
  • The largest China Pharma Holdings buyer in Q4 2016 was Virtu KCG Holdings, an estimated $5.85K added.
  • The largest China Pharma Holdings seller in Q4 2016 was Susquehanna International Group, an estimated $7K sold.

Based on aggregated 13F filings for Q4 2016.